Safety and efficacy of tazarotene foam for the treatment of acne vulgaris.

Abstract

BACKGROUND:

Tazarotene foam is the first topical retinoid foam approved for the treatment of acne vulgaris.

OBJECTIVE:

To review the safety and efficacy studies of tazarotene foam in the treatment of moderate to severe acne.

METHODS:

Five Phase I safety studies in normal controls are reviewed and two Phase III safety and efficacy studies in patients with moderate to severe acne are reviewed.

CONCLUSION:

Tazarotene foam, 0.1% was effective in the treatment of moderate to severe acne vulgaris with an acceptable tolerability profile. This treatment provides a cosmetically favorable alternative for topical retinoid therapy.

• Authors: Erica L Epstein, Linda Stein Gold
• Journal: Clinical, cosmetic and investigational dermatology (Clin Cosmet Investig Dermatol) Vol. 6 Pg. 123-5 ( 2013) ISSN: 1178-7015 [Print] New Zealand
• PMID: 23696711 (Publication Type: Journal Article)